Filing Details

Accession Number:
0001209191-20-007250
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-06 17:48:42
Reporting Period:
2020-02-04
Accepted Time:
2020-02-06 17:48:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1653087 Alector Inc. ALEC Biological Products, (No Disgnostic Substances) (2836) 462702363
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1757776 Sabah Oney C/O Alector, Inc.
131 Oyster Point Blvd, Suite 600
South San Francisco CA 94080
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-04 16,667 $8.16 610,585 No 4 M Direct
Common Stock Disposition 2020-02-04 16,667 $30.00 593,918 No 4 S Direct
Common Stock Disposition 2020-02-06 100 $35.00 593,818 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2020-02-04 16,667 $0.00 16,667 $8.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
100,000 2028-07-01 No 4 M Direct
Footnotes
  1. The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
  2. One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and an additional one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.